Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-08-13

FDA Approved: NARATRIPTAN — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Naratriptan from Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals Inc. to market the Naratriptan generic for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naratriptan (Naratriptan)

Snippet

SUPPL AP for NARATRIPTAN (NARATRIPTAN)